Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6859-2 (MIR6859-2) is a human microRNA gene encoding a small, non-coding RNA molecule involved in the regulation of gene expression at the post-transcriptional level[1][3]. Like all microRNAs, MIR6859-2 acts by associating with Argonaute proteins and the RNA-induced silencing complex (RISC) to bind target mRNAs, leading to inhibition of translation or mRNA degradation, typically through imperfect sequence complementarity[2]. The functional mature product of MIR6859-2, miR-6859-3p, has been predicted to suppress the expression of the transcription factor SOX9 in breast cancer cell lines, though the evidence suggests it acts indirectly and with less potency compared to other miRNAs like miR-134-3p and miR-224-3p[1]. While miR-6859-3p can influence gene expression patterns relevant to cancer biology, MIR6859-2 itself is not currently recognized or classified as a druggable or therapeutic target, receptor, enzyme, or other protein of direct pharmacological relevance. There are no known drugs targeting MIR6859-2, and its clinical utility as a biomarker or therapeutic agent has not been established[1][3]. The available information does not indicate any specific safety concerns or therapeutic challenges associated with MIR6859-2. Clarification: - MIR6859-2 is *not a receptor, enzyme, transporter, or classical therapeutic target*, but rather a gene encoding a small regulatory RNA. - It may be referenced in disease contexts associated with altered microRNA expression but is not directly targeted by any approved or experimental drugs. - "MIR6859-2" is the accepted gene symbol; "miR-6859-2" typically refers to the mature or processed microRNA derived from this gene. - There is no evidence for direct ligand or drug interaction, nor is it involved in canonical drug mechanisms of action. Note: MIR6859-2's role in disease and function remains ancillary and regulatory, consistent with microRNA biology, and its main relevance is to gene expression profiling and experimental functional genomics[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6859-2 (MIR6859-2).